A Kidney-Targeted Nanoparticle to Augment Renal Lymphatic Density Decreases Blood Pressure in Hypertensive Mice

Chronic interstitial inflammation and renal infiltration of activated immune cells play an integral role in hypertension. Lymphatics regulate inflammation through clearance of immune cells and excess interstitial fluid. Previously, we demonstrated increasing renal lymphangiogenesis prevents hyperten...

Full description

Bibliographic Details
Main Authors: Bethany L. Goodlett, Chang Sun Kang, Eunsoo Yoo, Shobana Navaneethabalakrishnan, Dakshnapriya Balasubbramanian, Sydney E. Love, Braden M. Sims, Daniela L. Avilez, Winter Tate, Delilah R. Chavez, Gaurav Baranwal, Mary B. Nabity, Joseph M. Rutkowski, Dongin Kim, Brett M. Mitchell
Format: Article
Language:English
Published: MDPI AG 2021-12-01
Series:Pharmaceutics
Subjects:
Online Access:https://www.mdpi.com/1999-4923/14/1/84
_version_ 1797491114233561088
author Bethany L. Goodlett
Chang Sun Kang
Eunsoo Yoo
Shobana Navaneethabalakrishnan
Dakshnapriya Balasubbramanian
Sydney E. Love
Braden M. Sims
Daniela L. Avilez
Winter Tate
Delilah R. Chavez
Gaurav Baranwal
Mary B. Nabity
Joseph M. Rutkowski
Dongin Kim
Brett M. Mitchell
author_facet Bethany L. Goodlett
Chang Sun Kang
Eunsoo Yoo
Shobana Navaneethabalakrishnan
Dakshnapriya Balasubbramanian
Sydney E. Love
Braden M. Sims
Daniela L. Avilez
Winter Tate
Delilah R. Chavez
Gaurav Baranwal
Mary B. Nabity
Joseph M. Rutkowski
Dongin Kim
Brett M. Mitchell
author_sort Bethany L. Goodlett
collection DOAJ
description Chronic interstitial inflammation and renal infiltration of activated immune cells play an integral role in hypertension. Lymphatics regulate inflammation through clearance of immune cells and excess interstitial fluid. Previously, we demonstrated increasing renal lymphangiogenesis prevents hypertension in mice. We hypothesized that targeted nanoparticle delivery of vascular endothelial growth factor-C (VEGF-C) to the kidney would induce renal lymphangiogenesis, lowering blood pressure in hypertensive mice. A kidney-targeting nanoparticle was loaded with a VEGF receptor-3-specific form of VEGF-C and injected into mice with angiotensin II-induced hypertension or LNAME-induced hypertension every 3 days. Nanoparticle-treated mice exhibited increased renal lymphatic vessel density and width compared to hypertensive mice injected with VEGF-C alone. Nanoparticle-treated mice exhibited decreased systolic blood pressure, decreased pro-inflammatory renal immune cells, and increased urinary fractional excretion of sodium. Our findings demonstrate that pharmacologically expanding renal lymphatics decreases blood pressure and is associated with favorable alterations in renal immune cells and increased sodium excretion.
first_indexed 2024-03-10T00:42:47Z
format Article
id doaj.art-0a0fdc36837b49b6852e2b32aa7824d6
institution Directory Open Access Journal
issn 1999-4923
language English
last_indexed 2024-03-10T00:42:47Z
publishDate 2021-12-01
publisher MDPI AG
record_format Article
series Pharmaceutics
spelling doaj.art-0a0fdc36837b49b6852e2b32aa7824d62023-11-23T15:03:36ZengMDPI AGPharmaceutics1999-49232021-12-011418410.3390/pharmaceutics14010084A Kidney-Targeted Nanoparticle to Augment Renal Lymphatic Density Decreases Blood Pressure in Hypertensive MiceBethany L. Goodlett0Chang Sun Kang1Eunsoo Yoo2Shobana Navaneethabalakrishnan3Dakshnapriya Balasubbramanian4Sydney E. Love5Braden M. Sims6Daniela L. Avilez7Winter Tate8Delilah R. Chavez9Gaurav Baranwal10Mary B. Nabity11Joseph M. Rutkowski12Dongin Kim13Brett M. Mitchell14Department of Medical Physiology, College of Medicine, Texas A&M University, Bryan, TX 77807, USADepartment of Pharmaceutical Sciences, College of Pharmacy, Texas A&M University, College Station, TX 77843, USADepartment of Pharmaceutical Sciences, College of Pharmacy, Texas A&M University, College Station, TX 77843, USADepartment of Medical Physiology, College of Medicine, Texas A&M University, Bryan, TX 77807, USADepartment of Medical Physiology, College of Medicine, Texas A&M University, Bryan, TX 77807, USADepartment of Medical Physiology, College of Medicine, Texas A&M University, Bryan, TX 77807, USADepartment of Medical Physiology, College of Medicine, Texas A&M University, Bryan, TX 77807, USADepartment of Medical Physiology, College of Medicine, Texas A&M University, Bryan, TX 77807, USADepartment of Medical Physiology, College of Medicine, Texas A&M University, Bryan, TX 77807, USADepartment of Medical Physiology, College of Medicine, Texas A&M University, Bryan, TX 77807, USADepartment of Medical Physiology, College of Medicine, Texas A&M University, Bryan, TX 77807, USADepartment of Veterinary Pathobiology, College of Veterinary Medicine & Biomedical Science, Texas A&M University, College Station, TX 77843, USADepartment of Medical Physiology, College of Medicine, Texas A&M University, Bryan, TX 77807, USADepartment of Pharmaceutical Sciences, College of Pharmacy, Texas A&M University, College Station, TX 77843, USADepartment of Medical Physiology, College of Medicine, Texas A&M University, Bryan, TX 77807, USAChronic interstitial inflammation and renal infiltration of activated immune cells play an integral role in hypertension. Lymphatics regulate inflammation through clearance of immune cells and excess interstitial fluid. Previously, we demonstrated increasing renal lymphangiogenesis prevents hypertension in mice. We hypothesized that targeted nanoparticle delivery of vascular endothelial growth factor-C (VEGF-C) to the kidney would induce renal lymphangiogenesis, lowering blood pressure in hypertensive mice. A kidney-targeting nanoparticle was loaded with a VEGF receptor-3-specific form of VEGF-C and injected into mice with angiotensin II-induced hypertension or LNAME-induced hypertension every 3 days. Nanoparticle-treated mice exhibited increased renal lymphatic vessel density and width compared to hypertensive mice injected with VEGF-C alone. Nanoparticle-treated mice exhibited decreased systolic blood pressure, decreased pro-inflammatory renal immune cells, and increased urinary fractional excretion of sodium. Our findings demonstrate that pharmacologically expanding renal lymphatics decreases blood pressure and is associated with favorable alterations in renal immune cells and increased sodium excretion.https://www.mdpi.com/1999-4923/14/1/84kidneylymphaticsinflammationimmunityhypertension
spellingShingle Bethany L. Goodlett
Chang Sun Kang
Eunsoo Yoo
Shobana Navaneethabalakrishnan
Dakshnapriya Balasubbramanian
Sydney E. Love
Braden M. Sims
Daniela L. Avilez
Winter Tate
Delilah R. Chavez
Gaurav Baranwal
Mary B. Nabity
Joseph M. Rutkowski
Dongin Kim
Brett M. Mitchell
A Kidney-Targeted Nanoparticle to Augment Renal Lymphatic Density Decreases Blood Pressure in Hypertensive Mice
Pharmaceutics
kidney
lymphatics
inflammation
immunity
hypertension
title A Kidney-Targeted Nanoparticle to Augment Renal Lymphatic Density Decreases Blood Pressure in Hypertensive Mice
title_full A Kidney-Targeted Nanoparticle to Augment Renal Lymphatic Density Decreases Blood Pressure in Hypertensive Mice
title_fullStr A Kidney-Targeted Nanoparticle to Augment Renal Lymphatic Density Decreases Blood Pressure in Hypertensive Mice
title_full_unstemmed A Kidney-Targeted Nanoparticle to Augment Renal Lymphatic Density Decreases Blood Pressure in Hypertensive Mice
title_short A Kidney-Targeted Nanoparticle to Augment Renal Lymphatic Density Decreases Blood Pressure in Hypertensive Mice
title_sort kidney targeted nanoparticle to augment renal lymphatic density decreases blood pressure in hypertensive mice
topic kidney
lymphatics
inflammation
immunity
hypertension
url https://www.mdpi.com/1999-4923/14/1/84
work_keys_str_mv AT bethanylgoodlett akidneytargetednanoparticletoaugmentrenallymphaticdensitydecreasesbloodpressureinhypertensivemice
AT changsunkang akidneytargetednanoparticletoaugmentrenallymphaticdensitydecreasesbloodpressureinhypertensivemice
AT eunsooyoo akidneytargetednanoparticletoaugmentrenallymphaticdensitydecreasesbloodpressureinhypertensivemice
AT shobananavaneethabalakrishnan akidneytargetednanoparticletoaugmentrenallymphaticdensitydecreasesbloodpressureinhypertensivemice
AT dakshnapriyabalasubbramanian akidneytargetednanoparticletoaugmentrenallymphaticdensitydecreasesbloodpressureinhypertensivemice
AT sydneyelove akidneytargetednanoparticletoaugmentrenallymphaticdensitydecreasesbloodpressureinhypertensivemice
AT bradenmsims akidneytargetednanoparticletoaugmentrenallymphaticdensitydecreasesbloodpressureinhypertensivemice
AT danielalavilez akidneytargetednanoparticletoaugmentrenallymphaticdensitydecreasesbloodpressureinhypertensivemice
AT wintertate akidneytargetednanoparticletoaugmentrenallymphaticdensitydecreasesbloodpressureinhypertensivemice
AT delilahrchavez akidneytargetednanoparticletoaugmentrenallymphaticdensitydecreasesbloodpressureinhypertensivemice
AT gauravbaranwal akidneytargetednanoparticletoaugmentrenallymphaticdensitydecreasesbloodpressureinhypertensivemice
AT marybnabity akidneytargetednanoparticletoaugmentrenallymphaticdensitydecreasesbloodpressureinhypertensivemice
AT josephmrutkowski akidneytargetednanoparticletoaugmentrenallymphaticdensitydecreasesbloodpressureinhypertensivemice
AT donginkim akidneytargetednanoparticletoaugmentrenallymphaticdensitydecreasesbloodpressureinhypertensivemice
AT brettmmitchell akidneytargetednanoparticletoaugmentrenallymphaticdensitydecreasesbloodpressureinhypertensivemice
AT bethanylgoodlett kidneytargetednanoparticletoaugmentrenallymphaticdensitydecreasesbloodpressureinhypertensivemice
AT changsunkang kidneytargetednanoparticletoaugmentrenallymphaticdensitydecreasesbloodpressureinhypertensivemice
AT eunsooyoo kidneytargetednanoparticletoaugmentrenallymphaticdensitydecreasesbloodpressureinhypertensivemice
AT shobananavaneethabalakrishnan kidneytargetednanoparticletoaugmentrenallymphaticdensitydecreasesbloodpressureinhypertensivemice
AT dakshnapriyabalasubbramanian kidneytargetednanoparticletoaugmentrenallymphaticdensitydecreasesbloodpressureinhypertensivemice
AT sydneyelove kidneytargetednanoparticletoaugmentrenallymphaticdensitydecreasesbloodpressureinhypertensivemice
AT bradenmsims kidneytargetednanoparticletoaugmentrenallymphaticdensitydecreasesbloodpressureinhypertensivemice
AT danielalavilez kidneytargetednanoparticletoaugmentrenallymphaticdensitydecreasesbloodpressureinhypertensivemice
AT wintertate kidneytargetednanoparticletoaugmentrenallymphaticdensitydecreasesbloodpressureinhypertensivemice
AT delilahrchavez kidneytargetednanoparticletoaugmentrenallymphaticdensitydecreasesbloodpressureinhypertensivemice
AT gauravbaranwal kidneytargetednanoparticletoaugmentrenallymphaticdensitydecreasesbloodpressureinhypertensivemice
AT marybnabity kidneytargetednanoparticletoaugmentrenallymphaticdensitydecreasesbloodpressureinhypertensivemice
AT josephmrutkowski kidneytargetednanoparticletoaugmentrenallymphaticdensitydecreasesbloodpressureinhypertensivemice
AT donginkim kidneytargetednanoparticletoaugmentrenallymphaticdensitydecreasesbloodpressureinhypertensivemice
AT brettmmitchell kidneytargetednanoparticletoaugmentrenallymphaticdensitydecreasesbloodpressureinhypertensivemice